Drug Type Small molecule drug |
Synonyms BrP 01096, BrP-01096, BrP01096 |
Target |
Action antagonists |
Mechanism OX2R antagonists(Orexin receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Sleep Initiation and Maintenance Disorders | Phase 1 | China | 13 May 2024 | |
| Sleep Initiation and Maintenance Disorders | Phase 1 | China | 13 May 2024 |





